Dalton King
19Patents
7h-index
42Co-inventors
66Inventor score
Filing activity: Dec 19, 1996 → Oct 28, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5824805A | Branched hydrazone linkers | Chemistry; Metallurgy | 167 | Expired |
| US6759509B1 | Branched peptide linkers | Human Necessities | 135 | Expired |
| US6512101B1 | Branched hydrazone linkers | Chemistry; Metallurgy | 34 | Expired |
| US7863291B2 | Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligands | Chemistry; Metallurgy | 15 | Active |
| US5939405A | Phosphate derivatives of diaryl 1,3,4-oxadiazolone | Human Necessities | 14 | Expired |
| US7105516B2 | Compounds for the treatment of premature ejaculation | Chemistry; Metallurgy | 10 | Expired |
| US8309577B2 | Quinuclidine compounds as α-7 nicotinic acetylcholine receptor ligands | Chemistry; Metallurgy | 8 | Active |
| US6777437B2 | Cyclopropylindole derivatives as selective serotonin reuptake inhibitors | Chemistry; Metallurgy | 7 | Expired |
| US10933069B2 | Compounds, compositions, and methods for treatment of diseases involving acidic or hypoxic diseased tissues | Human Necessities | 5 | Active |
| US8278320B2 | Azabicyclo[2.2.1]heptane compounds as alpha-7 nicotinic acetylcholine receptor ligands | Chemistry; Metallurgy | 4 | Active |
| US9221796B2 | Selective NR2B antagonists | Chemistry; Metallurgy | 4 | Active |
| US8507516B2 | Azabicyclic compounds as alpha-7 nicotinic acetylcholine receptor ligands | Chemistry; Metallurgy | 4 | Active |
| US8481555B2 | Aza-bicyclic amine N-oxide compounds as alpha-7 nicotinic acetylcholine receptor ligand pro-drugs | Human Necessities | 4 | Active |
| US6613786B2 | Thiophenyl triazol-3-one derivatives as smooth muscle relaxants | Chemistry; Metallurgy | 2 | Expired |
| US7049314B2 | Cyclopentyl indole derivatives | Chemistry; Metallurgy | 2 | Expired |
| US8722670B2 | Selective NR2B antagonists | Chemistry; Metallurgy | 2 | Active |
| US12427157B2 | Methods for treatment of diseases involving acidic or hypoxic diseased tissues | Human Necessities | 0 | Active |
| US8841301B2 | Selective NR2B antagonists | Chemistry; Metallurgy | 0 | Active |
| US7977362B2 | Alpha-(N-benzenesulfonamido)cycloalkyl derivatives | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.